Subscribe To
CATX / Perspective Therapeutics (CATX) Reports Q2 Loss, Lags Revenue Estimates
CATX News
By GlobeNewsWire
August 30, 2023
Perspective Therapeutics to Present at the World Molecular Imaging Congress 2023
RICHLAND, WASH. & CORALVILLE, IOWA, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Perspective T h erapeutics, Inc. (“Perspective” or “the Company”) (NYS more_horizontal
By Zacks Investment Research
August 11, 2023
Perspective Therapeutics (CATX) Reports Q2 Loss, Lags Revenue Estimates
Perspective Therapeutics (CATX) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compare more_horizontal
By GlobeNewsWire
May 24, 2023
Perspective Therapeutics to Present at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS)
Three poster presentations from Perspective Therapeutics' scientists and collaborators explore combinations of immunotherapy and targeted alpha-partic more_horizontal